Immunosuppressive tumor microenvironment contributes to tumor progression in diffuse large B-cell lymphoma upon anti-CD19 chimeric antigen receptor T therapy. - Yan Z; Li L; Fu D; Wu W; Qiao N; Huang Y; Jiang L; Wu D; Hu Y; Zhang H; Xu P; Cheng S; et al. (Frontiers of medicine, 2023)